[title]
[author]
[shortEnglishNames]
[pubIssue]
DOI:
[Doi]
(PDF [paperSize]K)
[HTML] [XML]
Back
Home
Submission
Articles
Journals
Book
Services
Blog
Back
Search
Menu
Sign in
Journals by Subject
Journals by Title
Search
Correlation of an
ex Vivo
Model with Clinical Application of an Epigenetic Modifier, Inhibiting Tumor Growth and Metastasis, in Resistant Cholangiocarcinoma—A Case Study
M. A. Nezami,
Aron Gould Simon,
Geoffrey Bartholomeusz
J. Cancer Ther.
Vol.7 No.1, January 28, 2016
DOI:
10.4236/jct.2016.71006
(PDF 560K)
HTML
XML
Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)
Mohammad Nezami,
Steve Hager
J. Cancer Ther.
Vol.9 No.11, November 14, 2018
DOI:
10.4236/jct.2018.911072
(PDF 3494K)
HTML
XML
Evidence Based Medicine, in Precision Oncology
M. Nezami,
Steve Hager
J. Cancer Ther.
Vol.9 No.9, September 11, 2018
DOI:
10.4236/jct.2018.99057
(PDF 2657K)
HTML
XML
Biological Modulation of Parp Inhibition in Triple Negative Breast Cancer, a Combinational Approach Implementing Multitargeted Epigenetic Therapy (Mtet) with Parp Inhibition, in Advanced Breast Cancer: A Case Study
M. Nezami,
Steve Hager,
Julie Taguchi
J. Cancer Ther.
Vol.9 No.9, September 11, 2018
DOI:
10.4236/jct.2018.99060
(PDF 2152K)
HTML
XML
Sequential and Dual Inhibition of Pleiotropic Targets in Cancer—A Novel Strategy to Sensitize Tumor Cells to Targeted Therapies and Overcome Resistance
M. Nezami
J. Cancer Ther.
Vol.10 No.2, February 21, 2019
DOI:
10.4236/jct.2019.102013
(PDF 2513K)
HTML
XML
About SCIRP
|
Sitemap
|
News
|
Jobs
Full Site
Copyright © 2020 Scientific Research Publishing Inc. All Rights Reserved.
Top
